rc 3095 has been researched along with Gastritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, JH; Dal-Pizzol, F; Ferreira, GK; Petronilho, F; Rezin, GT; Roesler, R; Schwartsmann, G; Steckert, AV; Streck, EL | 1 |
| Araújo, JH; Cardoso, MR; Dal-Pizzol, F; Daufenbach, JF; Gonçalves, CL; Petronilho, FC; Rezin, GT; Roesler, R; Schwartsmann, G; Streck, EL | 1 |
2 other study(ies) available for rc 3095 and Gastritis
| Article | Year |
|---|---|
Effect of a gastrin-releasing peptide receptor antagonist and a proton pump inhibitor association in an animal model of gastritis.
Topics: Animals; Bombesin; Disease Models, Animal; Gastric Mucosa; Gastritis; Indomethacin; Lipid Peroxidation; Male; Mitochondria; Omeprazole; Peptide Fragments; Protein Carbonylation; Proton Pump Inhibitors; Rats; Rats, Wistar; Receptors, Bombesin; Superoxides; Thiobarbiturates | 2009 |
Gastrin-releasing peptide receptor antagonist or N-acetylcysteine combined with omeprazol protect against mitochondrial complex II inhibition in a rat model of gastritis.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bombesin; Drug Therapy, Combination; Electron Transport; Electron Transport Complex II; Electron Transport Complex III; Gastric Mucosa; Gastritis; Indomethacin; Male; Mitochondria; Omeprazole; Peptide Fragments; Proton Pump Inhibitors; Rats; Rats, Wistar; Receptors, Bombesin; Severity of Illness Index; Stomach; Stomach Ulcer | 2011 |